Australia seems poised to welcome a groundbreaking treatment for excess weight: Retatrutide. This dual molecule – targeting on both GLP-1 and GIP receptors – has remarkable results in clinical studies, pointing to substantial reductions in body fat. While availability is pending with Australian regulators, many individuals struggling weight-rel